[go: up one dir, main page]

CN106215239A - A kind of preparation method of crosslinked antimicrobial type acellular matrix material - Google Patents

A kind of preparation method of crosslinked antimicrobial type acellular matrix material Download PDF

Info

Publication number
CN106215239A
CN106215239A CN201610771360.0A CN201610771360A CN106215239A CN 106215239 A CN106215239 A CN 106215239A CN 201610771360 A CN201610771360 A CN 201610771360A CN 106215239 A CN106215239 A CN 106215239A
Authority
CN
China
Prior art keywords
acellular matrix
matrix material
quaternary ammonium
add
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610771360.0A
Other languages
Chinese (zh)
Other versions
CN106215239B (en
Inventor
但年华
但卫华
陈宁
陈一宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan University
Original Assignee
Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan University filed Critical Sichuan University
Priority to CN201610771360.0A priority Critical patent/CN106215239B/en
Publication of CN106215239A publication Critical patent/CN106215239A/en
Application granted granted Critical
Publication of CN106215239B publication Critical patent/CN106215239B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633Extracellular matrix [ECM]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention discloses the preparation method of a kind of antimicrobial form acellular matrix material.The present invention uses oxidation chitosan quaternary ammonium salt crosslinking acellular matrix material, utilize and form crosslinking between multiple aldehyde radicals and the active group on acellular matrix on oxidation chitosan quaternary ammonium salt, improve the structural stability of material, chitosan quaternary ammonium salt is grafted in acellular matrix material simultaneously, thus gives acellular matrix material high antibacterial bacteriostatic performance.The crosslinking of material can be united two into one by this method with endowing antibacterial, is the preparation method of a kind of novel functional acellular matrix material, can be widely applied to technical field of biological material.

Description

一种交联抗菌型脱细胞基质材料的制备方法A preparation method of cross-linked antibacterial acellular matrix material

技术领域technical field

本发明涉及一种抗菌型脱细胞基质材料的制备方法,应用于生物材料领域。The invention relates to a preparation method of an antibacterial decellularized matrix material, which is applied in the field of biological materials.

背景技术Background technique

脱细胞基质材料是通过物理、化学和生物的方法处理基质材料,进行脱细胞处理、除去相关的抗原后获得的材料。它除去了天然材料中的细胞成分,保留了基质成分,有效降低了天然材料的免疫原性,同时能够保持基质材料的基本结构和性能(如宏观编织结构、微观孔隙结构、物理机械强度等)。常见的脱细胞基质材料有脱细胞真皮基质、脱细胞角膜基质、羊膜脱细胞基质、猪主动脉脱细胞基质、牛(或猪)心包脱细胞基质、猪小肠黏膜下脱细胞基质、尿道脱细胞基质、脱细胞软骨,可用于皮肤、血管、瓣膜、泌尿道等的修复或组织填充,已广泛应用于医疗领域(张晨,王志军,高景恒. 脱细胞组织基质的研究进展.大连大学学报,2007,28(3):57-60)。The decellularized matrix material is obtained by treating the matrix material with physical, chemical and biological methods, performing decellularization treatment, and removing related antigens. It removes the cellular components in natural materials, retains matrix components, effectively reduces the immunogenicity of natural materials, and at the same time maintains the basic structure and properties of matrix materials (such as macroscopic weaving structure, microscopic pore structure, physical and mechanical strength, etc.) . Common acellular matrix materials include acellular dermal matrix, acellular corneal stroma, amniotic membrane acellular matrix, porcine aortic acellular matrix, bovine (or porcine) pericardial acellular matrix, porcine small intestinal submucosal acellular matrix, and urethral acellular matrix Matrix and decellularized cartilage can be used for repair or tissue filling of skin, blood vessels, valves, urinary tract, etc., and have been widely used in the medical field (Zhang Chen, Wang Zhijun, Gao Jingheng. Research progress of decellularized tissue matrix. Journal of Dalian University, 2007 , 28(3):57-60).

通过交联可以消除或降低免疫原性、改善物理机械性能、提高耐降解能力,更好地满足使用的需要。物理交联法(如热脱氢)由于局限于材料表面且交联度程度低,未能广泛应用。合成交联剂来源广泛,可以通过分子设计的方法获得特定的分子结构,引入多个化学活性基团到交联剂分子中,因而交联高;但合成交联剂(如戊二醛)由于副产物和纯度不足等原因,容易导致交联后的材料生物相容性差。天然产物及其衍生物交联剂(如京尼平),相对生物相容性好,但往往品种较少,制备和纯化成本相对较高,无法大规模产业化应用。Cross-linking can eliminate or reduce immunogenicity, improve physical and mechanical properties, increase resistance to degradation, and better meet the needs of use. Physical crosslinking methods (such as thermal dehydrogenation) have not been widely used because they are limited to the surface of the material and the degree of crosslinking is low. Synthetic cross-linking agents have a wide range of sources, and specific molecular structures can be obtained by molecular design methods, and multiple chemically active groups are introduced into the cross-linking agent molecules, so the cross-linking is high; however, synthetic cross-linking agents (such as glutaraldehyde) are due to The reasons such as by-products and insufficient purity easily lead to poor biocompatibility of the cross-linked material. Natural products and their derivative cross-linking agents (such as genipin) have relatively good biocompatibility, but there are often fewer varieties, and the cost of preparation and purification is relatively high, so they cannot be used in large-scale industrial applications.

近年来,随着科学的进步,以氧化天然多糖类为代表的天然产物衍生物交联剂,成为研究热点。该类交联剂以天然糖类为母体,通过氧化形成多个醛基,从而使糖类具有交联性能。由于多糖生物相容性好,引入到生物材料中后,仍能保证交联后材料的具有良好的生物相容性。例如,将海藻酸盐氧化制备得到的氧化海藻酸钠被用作生物医用材料交联剂,取得了较好的效果( Hu, Y, Lju, L,Gu ZP, Dan, WH et al. Modification of collagenwith a natural derived cross-linker,alginate dialdehyde[J]. CARBOHYDRATEPOLYMERS,2014,102: 324-332。)此种交联剂拥有较高的交联度,克服了物理交联程度低的缺点;拥有较好的生物相容性,克服了合成交联剂生物相容性差的缺点。由于多糖类相对价廉易得,制备成本相对较低,因而具有广阔的应用前景,是比较理想的生物交联剂。In recent years, with the advancement of science, cross-linking agents of natural product derivatives represented by oxidized natural polysaccharides have become a research hotspot. This type of cross-linking agent uses natural sugars as the matrix, and forms multiple aldehyde groups through oxidation, so that the sugars have cross-linking properties. Due to the good biocompatibility of the polysaccharide, after being introduced into the biomaterial, good biocompatibility of the crosslinked material can still be ensured. For example, oxidized sodium alginate prepared by oxidizing alginate is used as a cross-linking agent for biomedical materials and has achieved good results (Hu, Y, Lju, L, Gu ZP, Dan, WH et al. Modification of collagen with a natural derived cross-linker, alginate dialdehyde[J]. CARBOHYDRATEPOLYMERS, 2014, 102: 324-332.) This kind of cross-linking agent has a higher degree of cross-linking, which overcomes the disadvantage of low degree of physical cross-linking; Good biocompatibility overcomes the disadvantage of poor biocompatibility of synthetic crosslinkers. Because polysaccharides are relatively cheap and easy to obtain, and the preparation cost is relatively low, they have broad application prospects and are ideal biological crosslinking agents.

生物材料在治疗疾病的同时,也存在一些问题。人们发现无论是长期或是短期留置在人体内的生物材料,常会引起各种细菌感染。据报道,美国一年内发生的血管内导管感染病例就有5万至20万例,死亡率高达20%。而且,这些感染一旦发生,即使应用正常剂量上百倍的药物也不能有效治疗,人体自身的免疫系统也不能清除这些细菌。据统计,45%的医院感染与生物材料的使用相关(罗建斌.抗菌生物材料的研究进展[J].高分子通报,2009,3:58-60)。而对于治疗体表创伤、烧伤的生物材料,感染也是最为普遍的并发症之一,它会导致伤口出现大量的渗出液,分解细胞外基质蛋白及多种生长因子,阻碍表皮再生及伤口闭合,从而显著影响康复的进程,甚至有可能导致烧创伤患者死亡(周英,许零.抗菌敷料研究进展. 中华损伤与修复杂志,2012,7(3):307-310)。可见,无论是应用于体表还是体内的生物材料,具有抗菌抑菌功能是生物材料需要具备的高级功能,生物材料抗菌性能的改善成为保证生物材料使用性能的关键技术之一。While biomaterials treat diseases, there are also some problems. It has been found that biomaterials, whether long-term or short-term indwelling in the human body, often cause various bacterial infections. According to reports, there are 50,000 to 200,000 cases of intravascular catheter infection in the United States within a year, and the mortality rate is as high as 20%. Moreover, once these infections occur, even the application of hundreds of times the normal dose of drugs cannot be effectively treated, and the body's own immune system cannot clear these bacteria. According to statistics, 45% of nosocomial infections are related to the use of biological materials (Luo Jianbin. Research progress of antibacterial biomaterials [J]. Polymer Bulletin, 2009, 3:58-60). Infection is also one of the most common complications for biomaterials used to treat body surface wounds and burns. It will cause a large amount of exudate in the wound, decompose extracellular matrix proteins and various growth factors, and hinder epidermal regeneration and wound closure. , thus significantly affecting the recovery process, and may even lead to the death of burn patients (Zhou Ying, Xu Ling. Research progress in antibacterial dressings. Chinese Journal of Injury and Repair, 2012, 7 (3): 307-310). It can be seen that whether it is applied to biomaterials on the body surface or in the body, antibacterial and antibacterial functions are the advanced functions that biomaterials need to possess. The improvement of antibacterial properties of biomaterials has become one of the key technologies to ensure the performance of biomaterials.

目前广泛使用的抗菌材料包括抗生素、金属离子、季铵盐、天然抗菌材料等。抗生素的使用,容易产生抗药性;金属离子(如银)则可能存在细胞易变质、性能不稳定、成本高等多种问题;普通季铵盐拥有良好的广谱抗菌性,但往往生物相容性不佳;天然抗菌材料(如壳聚糖)生物相容性优良,抗菌性能良好,但溶解性较差,限制了其应用。Currently widely used antibacterial materials include antibiotics, metal ions, quaternary ammonium salts, natural antibacterial materials, etc. The use of antibiotics is prone to drug resistance; metal ions (such as silver) may have various problems such as cell deterioration, unstable performance, and high cost; common quaternary ammonium salts have good broad-spectrum antibacterial properties, but are often biocompatible Poor; natural antibacterial materials (such as chitosan) have excellent biocompatibility and good antibacterial performance, but their solubility is poor, which limits their application.

壳聚糖季铵盐是将壳聚糖的氨基转变为季铵盐基团或者接枝低分子季铵盐而得到的产物。它属于聚阳离子化合物,具有良好的水溶性、絮凝性、生物相容性、吸湿保湿性和更好的抗菌性等特点,因此其应用范围相当广泛。(钟婧,洪艳,陈勇.壳聚糖季铵盐的最新研究进展. 中国组织工程研究与临床康复,2008,12(6):1115-1118)。Chitosan quaternary ammonium salt is a product obtained by converting the amino group of chitosan into a quaternary ammonium salt group or grafting a low molecular weight quaternary ammonium salt. It belongs to polycationic compound, which has the characteristics of good water solubility, flocculation, biocompatibility, moisture absorption and better antibacterial properties, so its application range is quite wide. (Zhong Jing, Hong Yan, Chen Yong. The latest research progress of chitosan quaternary ammonium salt. China Tissue Engineering Research and Clinical Rehabilitation, 2008, 12 (6): 1115-1118).

采用物理共混的方法,将壳聚糖季铵盐加入到生物材料中,能够赋予生物材料以抗菌抑菌功能,是目前普遍采用的方法。然而,壳聚糖季铵盐分子中缺少具有化学反应活性的基团,难以与生物材料形成牢固的共价键结合。物理共混加入的壳聚糖季铵盐容易从生物材料中产生迁移、流失,不能产生长久的抗菌抑菌性能,难以达到预期效果。Adding chitosan quaternary ammonium salt to biological materials by physical blending can endow biological materials with antibacterial and antibacterial functions, which is a commonly used method at present. However, chitosan quaternary ammonium salt lacks chemically reactive groups, making it difficult to form a strong covalent bond with biological materials. The chitosan quaternary ammonium salt added by physical blending is prone to migration and loss from biological materials, and cannot produce long-term antibacterial and antibacterial properties, and it is difficult to achieve the expected effect.

由上可见,目前的生物材料,一方面需要采用生物相容性优良的交联剂进行交联,同时需要赋予生物材料以良好的抗菌抑菌功能。目前的方法往往只能满足其中之一。能否将交联与抗菌合二为一,在交联的同时,赋予生物材料以抗菌性?我们在长期的生物材料交联研究中,提出了“功能化尺度交联”的新观点:即在交联的同时,赋予生物材料以其它功能。该观点为我们寻找和制备新一代功能型交联剂提供了新思路。采用兼具交联性和抗菌性的交联剂,既可以满足交联的需要,又可以赋予材料以抗菌性能。It can be seen from the above that, on the one hand, the current biomaterials need to be cross-linked with a cross-linking agent with excellent biocompatibility, and at the same time, it is necessary to endow the biomaterials with good antibacterial and antibacterial functions. Current methods often only satisfy one of them. Can crosslinking and antibacterial be combined into one, and at the same time of crosslinking, biomaterials can be endowed with antibacterial properties? In our long-term research on cross-linking of biomaterials, we proposed a new concept of "functionalized scale cross-linking": that is, while cross-linking, biomaterials are endowed with other functions. This point of view provides a new idea for us to find and prepare a new generation of functional crosslinkers. The use of a cross-linking agent with both cross-linking and antibacterial properties can not only meet the needs of cross-linking, but also endow the material with antibacterial properties.

氧化壳聚糖季铵盐,其母体为壳聚糖,本身具有良好的生物相容性;壳聚糖季铵盐经过选择性氧化后,产生多个化学活泼的醛基,因而能够与生物材料之间形成牢固的交联,提高材料的耐降解能力;同时在生物材料中接入了壳聚糖季铵盐结构,因而具有优良的抗菌抑菌性能,由于交联过程中生成了牢固的共价键,因而有效避免了抗菌剂的迁移和流失,克服了以往方法的缺点。本方法将生物材料的交联与赋予抗菌性能合二为一,同时达到了产生交联效果与赋予抗菌性的双重目的,是一种新型的功能性脱细胞基质材料的制备方法,可以广泛应用于生物材料领域。Oxidized chitosan quaternary ammonium salt, whose parent is chitosan, has good biocompatibility; after selective oxidation, chitosan quaternary ammonium salt produces multiple chemically active aldehyde groups, so it can be compatible with biological materials Form a strong cross-linking between them to improve the degradation resistance of the material; at the same time, the chitosan quaternary ammonium salt structure is inserted into the biological material, so it has excellent antibacterial and antibacterial properties. Valence bonds, thus effectively avoiding the migration and loss of antibacterial agents, overcoming the shortcomings of previous methods. This method combines the cross-linking of biological materials and the endowment of antibacterial properties into one, and simultaneously achieves the dual purposes of producing cross-linking effects and endowing antibacterial properties. It is a new preparation method for functional acellular matrix materials and can be widely used. in the field of biomaterials.

发明内容Contents of the invention

本发明的目的是针对现有技术的不足而提供一种抗菌型脱细胞基质材料的制备方法,它是由以下技术措施来实现的。The object of the present invention is to provide a preparation method of an antibacterial acellular matrix material for the deficiencies of the prior art, which is realized by the following technical measures.

一种抗菌型脱细胞基质材料的制备方法,其特征是:称取100重量份的脱细胞基质材料,在20~65℃下,加入100~1000重量份的pH值为3.0~10.5的缓冲液,处理10~60min;然后加入1~20重量份的氧化度为1~98%的氧化壳聚糖季铵盐,处理0.5~24.0小时;弃去反应废液,加入200~1000重量份的水,清洗10~30分钟;弃去清洗废液,加入100~1000重量份的pH值为3.0~10.5的缓冲液,加入0.5~2.0重量份的氨基酸,在20~65℃下,处理0.5~4.0小时;弃去废液,加入200~1000重量份的水,清洗20~60分钟;弃去废液,加入100~300重量份的水,加入0.1~1.0重量份的乳酸或乳酸钠,在20~35℃下,处理30~90分钟,将浴液pH调节至中性;弃去废液,加入200~1000重量份的30~42℃的注射水,清洗1~4h;弃去废液,加入200~1000重量份的30~42℃的注射水,清洗1~4h。A method for preparing an antibacterial acellular matrix material, characterized in that: Weigh 100 parts by weight of the acellular matrix material, and add 100 to 1000 parts by weight of a buffer solution with a pH value of 3.0 to 10.5 at 20 to 65°C , treated for 10-60min; then add 1-20 parts by weight of oxidized chitosan quaternary ammonium salt with an oxidation degree of 1-98%, and treat for 0.5-24.0 hours; discard the reaction waste liquid, and add 200-1000 parts by weight of water , wash for 10 to 30 minutes; discard the cleaning waste liquid, add 100 to 1000 parts by weight of a buffer solution with a pH value of 3.0 to 10.5, add 0.5 to 2.0 parts by weight of amino acids, and treat 0.5 to 4.0 parts at 20 to 65 ° C hours; discard the waste liquid, add 200-1000 parts by weight of water, and wash for 20-60 minutes; discard the waste liquid, add 100-300 parts by weight of water, add 0.1-1.0 parts by weight of lactic acid or sodium lactate, and At 35°C, treat for 30-90 minutes, adjust the pH of the bath liquid to neutral; discard the waste liquid, add 200-1000 parts by weight of water for injection at 30-42°C, and wash for 1-4 hours; discard the waste liquid, add 200-1000 parts by weight of water for injection at 30-42°C, wash for 1-4 hours.

根据权利要求1所述的抗菌型脱细胞基质材料的制备方法,其中所述的氧化壳聚糖季铵盐是指壳聚糖季铵盐经选择性氧化后形成的结构中含有多个醛基的壳聚糖季铵盐。The preparation method of antibacterial type acellular matrix material according to claim 1, wherein said oxidized chitosan quaternary ammonium salt refers to the structure formed by chitosan quaternary ammonium salt after selective oxidation containing multiple aldehyde groups chitosan quaternary ammonium salt.

根据权利要求1所述的抗菌型脱细胞基质材料的制备方法,其中所述的氨基酸,是指甘氨酸、精氨酸、赖氨酸和组氨酸。The preparation method of antibacterial acellular matrix material according to claim 1, wherein said amino acid refers to glycine, arginine, lysine and histidine.

根据权利要求1所述的抗菌型脱细胞基质材料的制备方法,其中所述的pH值为3.0~10.5的缓冲液,该pH是通过使用醋酸—盐酸缓冲溶液、磷酸盐缓冲溶液、硼酸—硼砂缓冲溶液、NaHCO3-NaOH缓冲溶液达到的。The preparation method of antibacterial acellular matrix material according to claim 1, wherein said buffer solution with a pH value of 3.0 to 10.5 is obtained by using acetic acid-hydrochloric acid buffer solution, phosphate buffer solution, boric acid-borax Buffer solution, NaHCO 3 -NaOH buffer solution.

权利要求1所述一种抗菌型脱细胞基质材料的制备方法,其特征在于该方法可用于脱细胞真皮基质、脱细胞角膜基质、羊膜脱细胞基质、猪主动脉脱细胞基质、心包脱细胞基质、猪小肠黏膜下脱细胞基质、尿道脱细胞基质、脱细胞软骨的制备中。The preparation method of an antibacterial acellular matrix material according to claim 1 is characterized in that the method can be used for acellular dermal matrix, acellular corneal matrix, amniotic membrane acellular matrix, porcine aortic acellular matrix, pericardial acellular matrix , In the preparation of porcine small intestinal submucosal acellular matrix, urethral acellular matrix, and acellular cartilage.

本发明中所用氧化壳寡糖季铵盐为医药级,其它材料均为分析纯或生物试剂。The quaternary ammonium salt of oxidized chitooligosaccharide used in the present invention is of pharmaceutical grade, and other materials are analytically pure or biological reagents.

本交联方法具有以下优点:This cross-linking method has the following advantages:

(1)交联程度高:由于氧化壳聚糖季铵盐分子含有多个醛基,可以与脱细胞基质材料中的氨基等产生多点结合,形成较高程度的交联。可以降低脱细胞基质材料的抗原性,改善的物理机械性能和耐降解性;(1) High degree of cross-linking: Since the oxidized chitosan quaternary ammonium salt molecule contains multiple aldehyde groups, it can combine with amino groups in the acellular matrix material at multiple points to form a higher degree of cross-linking. Can reduce the antigenicity of acellular matrix materials, improve physical and mechanical properties and degradation resistance;

(2)抗菌抑菌性能好:由于壳聚糖季铵盐较强的阳电荷,具有广谱抗菌性,抗菌性能优良,交联后的脱细胞基质材料中引入了壳聚糖季铵盐,因而就赋予了脱细胞基质材料以良好的抗菌抑菌功能;(2) Good antibacterial and antibacterial performance: due to the strong positive charge of chitosan quaternary ammonium salt, it has broad-spectrum antibacterial properties and excellent antibacterial performance. Chitosan quaternary ammonium salt is introduced into the cross-linked acellular matrix material, Therefore, the acellular matrix material is endowed with good antibacterial and antibacterial functions;

(3)抗菌抑菌性能持久:通过氧化壳聚糖季铵盐中的醛基与脱细胞基质材料中的氨基等形成牢固的共价键,键能大,稳定性高,因而有效避免了物理共混法易产生的壳聚糖季铵盐的迁移与流失的缺陷,可长期保持其抗菌抑菌性能;(3) Long-lasting antibacterial and antibacterial properties: strong covalent bonds are formed by oxidizing the aldehyde groups in the chitosan quaternary ammonium salt and the amino groups in the acellular matrix material, with large bond energy and high stability, thus effectively avoiding physical damage. The defect of migration and loss of chitosan quaternary ammonium salt, which is easy to be produced by the blending method, can maintain its antibacterial and antibacterial properties for a long time;

(4)生物相容性好:氧化壳聚糖季铵盐中醛基反应后,结构中余下壳聚糖季铵盐基团,而壳聚糖季铵盐来源于壳聚糖,因而继承了壳聚糖良好的生物相容性。采用氨基酸后处理,将可能残留的醛基除去,保证了交联材料的良好生物相容性;(4) Good biocompatibility: After the aldehyde group reaction in the oxidized chitosan quaternary ammonium salt, the chitosan quaternary ammonium salt group remains in the structure, and the chitosan quaternary ammonium salt is derived from chitosan, thus inheriting the Chitosan has good biocompatibility. Amino acid post-treatment is used to remove possible residual aldehyde groups, ensuring good biocompatibility of cross-linked materials;

(5)可调控性好:可以通过选择氧化壳聚糖的种类、控制氧化程度、控制交联剂的用量,来控制交联程度和抗菌性能;(5) Good controllability: the degree of cross-linking and antibacterial properties can be controlled by selecting the type of oxidized chitosan, controlling the degree of oxidation, and controlling the amount of cross-linking agent;

(6)可生物降解:由于壳聚糖季铵盐具有生物可降解性,接入到生物材料后,仍然可以保持交联材料的生物降解性,可以通过交联程度来调节其降解性能;(6) Biodegradable: Since the chitosan quaternary ammonium salt is biodegradable, it can still maintain the biodegradability of the cross-linked material after being inserted into the biological material, and its degradation performance can be adjusted by the degree of cross-linking;

(7)赋予生物材料以良好的亲水保湿性能:在生物材料中引入了壳聚糖季铵盐,将壳聚糖季铵盐的保湿性能赋予给生物材料,从而使交联后的材料具有良好的亲水、保湿性能;(7) Endow biological materials with good hydrophilic and moisturizing properties: chitosan quaternary ammonium salts are introduced into biological materials, and the moisturizing properties of chitosan quaternary ammonium salts are endowed to biological materials, so that the crosslinked materials have Good hydrophilic and moisturizing properties;

(8)颜色浅淡:经氧化壳聚糖季铵盐交联的胶原,可以保持白色,无戊二醛交联后的深黄色,亦无京尼平交联后的深蓝色;(8) Light color: the collagen cross-linked by oxidized chitosan quaternary ammonium salt can keep white, without the dark yellow after cross-linking with glutaraldehyde, and without the dark blue after cross-linking with genipin;

(9)原料价格低廉,可大规模产业化:氧化壳聚糖季铵盐与京尼平等优良交联剂相比,其价格更便宜,因而,本方法可以应用于工业化大生产,广泛应用于生物材料领域。(9) The price of raw materials is low, and it can be industrialized on a large scale: compared with the excellent crosslinking agent of genipal, oxidized chitosan quaternary ammonium salt is cheaper. Therefore, this method can be applied to large-scale industrial production and is widely used in field of biomaterials.

综上所述,本发明以氧化壳聚糖季铵盐为原料,将其应用于脱细胞基质材料的交联,一方面可以降低材料的抗原性,提高材料的结构稳定性和耐降解能力;同时能够赋予材料以良好的抗菌抑菌功能,是一种新型的功能性脱细胞基质材料的制备方法,可广泛地应用于生物材料领域。In summary, the present invention uses oxidized chitosan quaternary ammonium salt as a raw material and applies it to the crosslinking of acellular matrix materials. On the one hand, it can reduce the antigenicity of the material and improve the structural stability and degradation resistance of the material; At the same time, it can endow the material with good antibacterial and antibacterial functions, and is a novel preparation method of functional decellularized matrix material, which can be widely used in the field of biological materials.

具体实施方式detailed description

下面通过实例对本发明进行具体的描述,有必要在此指出的是,本实例只用于对本发明的进一步说明,而不能理解为对本发明保护范围的限制,该领域的技术熟练人员可以根据上述发明的内容作出一些非本质的改进和调整。The present invention is specifically described below by examples, it is necessary to point out that this example is only used for further illustration of the present invention, and can not be interpreted as the restriction to protection scope of the present invention, those skilled in the art can according to above-mentioned invention Some non-essential improvements and adjustments have been made to the content.

实施例1Example 1

(1)称取100重量份的脱细胞猪真皮基质,加入到反应器中;(1) Weighing 100 parts by weight of acellular porcine dermal matrix and adding it to the reactor;

(2) 加入130重量份的pH值为8.5的硼酸—硼砂缓冲溶液,转动30分种;(2) Add 130 parts by weight of boric acid-borax buffer solution with a pH value of 8.5, and rotate for 30 minutes;

(3)称取氧化度为8%的氧化N-羟丙基三甲基氯化铵壳聚糖8重量份,溶解于20重量份的蒸馏水中;(3) Take by weighing 8 parts by weight of oxidized N-hydroxypropyltrimethylammonium chloride chitosan with a degree of oxidation of 8%, and dissolve it in 20 parts by weight of distilled water;

(4)将氧化壳聚糖季铵盐的水溶液加入到反应器中,升温到37℃,反应16小时,倒去反应废液;(4) Add the aqueous solution of oxidized chitosan quaternary ammonium salt into the reactor, raise the temperature to 37°C, react for 16 hours, and pour off the reaction waste liquid;

(5)加入300重量份的纯水,清洗20分钟,倒去废液;(5) Add 300 parts by weight of pure water, wash for 20 minutes, and pour off the waste liquid;

(6)加入100重量份的37℃的pH值为8.5的硼酸—硼砂缓冲溶液,加入1.5重量份的赖氨酸,转动2小时,倒去废液;(6) Add 100 parts by weight of boric acid-borax buffer solution with a pH value of 8.5 at 37°C, add 1.5 parts by weight of lysine, rotate for 2 hours, and pour off the waste liquid;

(7)加入1000重量份的纯水,清洗30分钟,倒去废液;(7) Add 1000 parts by weight of pure water, wash for 30 minutes, and pour off the waste liquid;

(8)加入200重量份的纯水,加入0.5重量份的乳酸,处理1.5小时,弃去废液;(8) Add 200 parts by weight of pure water, add 0.5 parts by weight of lactic acid, treat for 1.5 hours, and discard the waste liquid;

(9)加入500重量份的的37℃的注射水,清洗1小时;倒去清洗液,再加入加入1000重量份的的37℃的注射水,清洗3小时。(9) Add 500 parts by weight of water for injection at 37°C and wash for 1 hour; pour off the cleaning solution, then add 1000 parts by weight of water for injection at 37°C and wash for 3 hours.

实施例2Example 2

(1)称取100重量份的牛心包脱细胞基质,加入到反应器中;(1) Weighing 100 parts by weight of bovine pericardium decellularized matrix and adding it to the reactor;

(2) 加入200重量份的pH值为4.8的醋酸—盐酸缓冲溶液,转动60分种;(2) Add 200 parts by weight of acetic acid-hydrochloric acid buffer solution with a pH value of 4.8, and rotate for 60 minutes;

(3)称取氧化度为80%的氧化N,N,N-三甲基壳聚糖季铵盐4重量份,溶解于50重量份的pH值为4.8的醋酸—盐酸缓冲溶液中;(3) Weigh 4 parts by weight of oxidized N, N, N-trimethyl chitosan quaternary ammonium salt with an oxidation degree of 80%, and dissolve it in 50 parts by weight of acetic acid-hydrochloric acid buffer solution with a pH value of 4.8;

(4)将氧化壳聚糖季铵盐的溶液加入到反应器中,升温到42℃,转动8小时,倒去反应废液;(4) Add the solution of oxidized chitosan quaternary ammonium salt into the reactor, raise the temperature to 42°C, rotate for 8 hours, and pour off the reaction waste liquid;

(5)加入500重量份的纯水,转动20分钟,倒去废液;(5) Add 500 parts by weight of pure water, rotate for 20 minutes, and pour off the waste liquid;

(6)加入150重量份的pH值为4.8的醋酸—盐酸缓冲溶液,加入0.5重量份的精氨酸,在42℃下,转动4小时,倒去废液;(6) Add 150 parts by weight of acetic acid-hydrochloric acid buffer solution with a pH value of 4.8, add 0.5 parts by weight of arginine, rotate for 4 hours at 42°C, and pour off the waste liquid;

(7)加入800重量份的纯水,转动20分钟,倒去废液;(7) Add 800 parts by weight of pure water, rotate for 20 minutes, and pour off the waste liquid;

(8)加入100重量份的纯水,加入1.0重量份的乳酸钠,转动90分钟,倒去废液;(8) Add 100 parts by weight of pure water, add 1.0 parts by weight of sodium lactate, rotate for 90 minutes, and pour out the waste liquid;

(9)加入1000重量份的的42℃的注射水,清洗2小时;倒去清洗液,再加入加入500重量份的的42℃的注射水,清洗4小时。(9) Add 1000 parts by weight of water for injection at 42°C, and wash for 2 hours; pour off the cleaning solution, and then add 500 parts by weight of water for injection at 42°C, and wash for 4 hours.

实施例3Example 3

(1)称取100重量份的羊膜脱细胞基质,加入到反应器中;(1) Weighing 100 parts by weight of amniotic membrane decellularized matrix and adding it to the reactor;

(2)加入100重量份的pH值为9.4的NaHCO3-NaOH缓冲溶液,转动20分种;(2) Add 100 parts by weight of NaHCO 3 -NaOH buffer solution with a pH value of 9.4, and rotate for 20 minutes;

(3)称取氧化度为5%的氧化O-羟丙基三甲基氯化铵N-三甲基壳聚糖16重量份,溶解于50重量份的纯水中;(3) Weigh 16 parts by weight of oxidized O-hydroxypropyltrimethylammonium chloride N-trimethyl chitosan with a degree of oxidation of 5%, and dissolve it in 50 parts by weight of pure water;

(4)将氧化壳聚糖季铵盐的溶液加入到反应器中,升温到32℃,转动24小时,倒去反应废液;(4) Add the solution of oxidized chitosan quaternary ammonium salt into the reactor, raise the temperature to 32°C, rotate for 24 hours, and pour off the reaction waste liquid;

(5)加入800重量份的纯水,转动40分钟,倒去废液;(5) Add 800 parts by weight of pure water, rotate for 40 minutes, and pour off the waste liquid;

(6)加入150重量份pH值为9.4的NaHCO3-NaOH缓冲溶液,加入2.0重量份的甘氨酸,在32℃下反应1小时,倒去废液;(6) Add 150 parts by weight of NaHCO 3 -NaOH buffer solution with a pH value of 9.4, add 2.0 parts by weight of glycine, react at 32°C for 1 hour, and pour off the waste liquid;

(7)加入300重量份的纯水,转动15分钟,弃去废液;(7) Add 300 parts by weight of pure water, rotate for 15 minutes, and discard the waste liquid;

(8)加入300重量份的纯水,加入1.0重量份的乳酸,转动40分钟,弃去废液;(8) Add 300 parts by weight of pure water, add 1.0 parts by weight of lactic acid, rotate for 40 minutes, and discard the waste liquid;

(9)加入600重量份的的37℃的注射水,清洗2小时;倒去清洗液,再加入加入1000重量份的的32℃的注射水,清洗4小时;(9) Add 600 parts by weight of water for injection at 37°C, wash for 2 hours; pour off the cleaning solution, then add 1000 parts by weight of water for injection at 32°C, and wash for 4 hours;

(10)取出羊膜脱细胞基质,冷冻干燥。(10) Take out the amniotic membrane decellularized matrix and freeze-dry it.

Claims (5)

1. a preparation method for antimicrobial form acellular matrix material, is characterized in that: weigh the acellular matrix material of 100 weight portions Material, at 20~65 DEG C, adds the buffer that pH value is 3.0~10.5 of 100~1000 weight portions, processes 10~60min;So The oxidation chitosan quaternary ammonium salt that oxidizability is 1~98% of rear addition 1~20 weight portion, processes 0.5~24.0 hour;Discard anti- Answer waste liquid, add the water of 200~1000 weight portions, clean 10~30 minutes;Discard cleaning waste liquid, add 100~1000 weight Part the buffer that pH value is 3.0~10.5, add 0.5~2.0 weight portions aminoacid, at 20~65 DEG C, process 0.5~ 4.0 hour;Discard waste liquid, add the water of 200~1000 weight portions, clean 20~60 minutes;Discard waste liquid, add 100~300 The water of weight portion, adds lactic acid or the sodium lactate of 0.1~1.0 weight portions, at 20~35 DEG C, processes 30~90 minutes, will bath Liquid pH regulator is to neutral;Discard waste liquid, the injection water of 30~42 DEG C of addition 200~1000 weight portions, clean 1~4h;Discard Waste liquid, the injection water of 30~42 DEG C of addition 200~1000 weight portions, cleans 1~4h.
The preparation method of antimicrobial form acellular matrix material the most according to claim 1, wherein said oxidation chitosan The structure that quaternary ammonium salt is formed after referring to the oxidation of chitosan quaternary ammonium salt chosen property contains the chitosan quaternary ammonium salt of multiple aldehyde radicals.
The preparation method of antimicrobial form acellular matrix material the most according to claim 1, wherein said aminoacid, refer to Glycine, arginine, lysine and histidine.
The preparation method of antimicrobial form acellular matrix material the most according to claim 1, wherein said pH value be 3.0~ The buffer of 10.5, this pH is by using acetate hydrochloride buffer solution, phosphate buffered solution, boric acid Borax buffering molten Liquid, NaHCO3-NaOH buffer solution reaches.
5. the preparation method of a kind of antimicrobial form acellular matrix material described in claim 1, it is characterised in that the method can be used for Acellular dermal matrix, cell-eliminating coanea matrix, human acellular amniotic membrane matrix, porcine aorta acellular matrix, pericardium take off cell base Under matter, intestinal mucosa in the preparation of acellular matrix, urethra acellular matrix, de-cellular cartilage.
CN201610771360.0A 2016-08-31 2016-08-31 A preparation method of cross-linked antibacterial acellular matrix material Active CN106215239B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610771360.0A CN106215239B (en) 2016-08-31 2016-08-31 A preparation method of cross-linked antibacterial acellular matrix material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610771360.0A CN106215239B (en) 2016-08-31 2016-08-31 A preparation method of cross-linked antibacterial acellular matrix material

Publications (2)

Publication Number Publication Date
CN106215239A true CN106215239A (en) 2016-12-14
CN106215239B CN106215239B (en) 2019-09-13

Family

ID=58072751

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610771360.0A Active CN106215239B (en) 2016-08-31 2016-08-31 A preparation method of cross-linked antibacterial acellular matrix material

Country Status (1)

Country Link
CN (1) CN106215239B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107823717A (en) * 2017-11-29 2018-03-23 四川大学 A kind of preparation method of anticalcium biological sticking patch
CN109731124A (en) * 2018-12-24 2019-05-10 山东朱氏药业集团有限公司 A kind of nano silver composite hydrogel dressing patch and preparation method thereof
CN111808792A (en) * 2020-05-28 2020-10-23 广州新诚生物科技有限公司 a cell culture medium
CN112569405A (en) * 2020-12-07 2021-03-30 四川大学 Preparation method of chitosan quaternary ammonium salt type acellular dermal matrix material
CN114272429A (en) * 2021-12-16 2022-04-05 成都汉丁新材料科技有限公司 Fetal bovine dermal matrix dressing and preparation method thereof
CN114681673A (en) * 2020-12-31 2022-07-01 杭州启明医疗器械股份有限公司 Crease-resistant dehydrated cross-linked biomaterial, and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101314055A (en) * 2007-05-28 2008-12-03 江阴奔翔生物科技有限公司 Acellular dermal matrix compound film material and preparation method thereof
CN102321195A (en) * 2011-09-09 2012-01-18 中国科学院海洋研究所 Chitosan aminoethyl quaternary ammonium salt derivative and preparation method thereof
CN103505759A (en) * 2013-07-04 2014-01-15 四川大学 Method used for modifying collagen with epoxy quaternary ammonium salt
CN104013995A (en) * 2014-06-26 2014-09-03 四川大学 Oxidation chitosan graft modified porcine dermal collagen micro-nano fiber membrane and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101314055A (en) * 2007-05-28 2008-12-03 江阴奔翔生物科技有限公司 Acellular dermal matrix compound film material and preparation method thereof
CN102321195A (en) * 2011-09-09 2012-01-18 中国科学院海洋研究所 Chitosan aminoethyl quaternary ammonium salt derivative and preparation method thereof
CN103505759A (en) * 2013-07-04 2014-01-15 四川大学 Method used for modifying collagen with epoxy quaternary ammonium salt
CN104013995A (en) * 2014-06-26 2014-09-03 四川大学 Oxidation chitosan graft modified porcine dermal collagen micro-nano fiber membrane and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YI JIA ET AL: "Oligoamines conjugated chitosan derivatives: Synthesis, characterization in vitro and in vivo biocompatibility evaluations", 《CARBOHYDRATE POLYMERS》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107823717A (en) * 2017-11-29 2018-03-23 四川大学 A kind of preparation method of anticalcium biological sticking patch
CN109731124A (en) * 2018-12-24 2019-05-10 山东朱氏药业集团有限公司 A kind of nano silver composite hydrogel dressing patch and preparation method thereof
CN111808792A (en) * 2020-05-28 2020-10-23 广州新诚生物科技有限公司 a cell culture medium
CN112569405A (en) * 2020-12-07 2021-03-30 四川大学 Preparation method of chitosan quaternary ammonium salt type acellular dermal matrix material
CN114681673A (en) * 2020-12-31 2022-07-01 杭州启明医疗器械股份有限公司 Crease-resistant dehydrated cross-linked biomaterial, and preparation method and application thereof
CN114272429A (en) * 2021-12-16 2022-04-05 成都汉丁新材料科技有限公司 Fetal bovine dermal matrix dressing and preparation method thereof

Also Published As

Publication number Publication date
CN106215239B (en) 2019-09-13

Similar Documents

Publication Publication Date Title
CN106215239B (en) A preparation method of cross-linked antibacterial acellular matrix material
Tang et al. Application of chitosan and its derivatives in medical materials
CN104013995B (en) Oxidation chitosan graft modification pig dermis collagen micro-nano fiber film and preparation method thereof
CN103272268B (en) Antibacterial cornea repairing material and preparation method thereof
CN102335451B (en) Medical colloid dressing with functions for inhibiting bacteria and promoting heal and application thereof
CN101905034B (en) Method for preparing biological polysaccharide self-assembly modificatory chitosan antibacterial biological material
CN112480434B (en) A kind of copper ion antibacterial hydrogel and preparation method and application
CN105079886A (en) Preparation method of oxidized nano-cellulose/collagen composite sponge
CN115124738B (en) A double-layer biomimetic drug-loaded hydrogel and its preparation and application
CN114452436B (en) Collagen-based injectable self-repairing hydrogel and preparation method thereof
CN110507842B (en) Bacterial cellulose/hyaluronic acid/epsilon-polylysine functional dressing and preparation method thereof
Yaşayan et al. Natural polymers for wound dressing applications
CN113069591A (en) Chitosan-calcium polyglutamate biological dressing and preparation method thereof
CN106421868A (en) Chitosan quaternary ammonium salt porcine acellular dermal matrix dressing material and preparation method thereof
CN104740683A (en) Cornea repair material with double-layer structure and preparation method of cornea repair material
CN104548201B (en) A kind of corneal tissue repair material and preparation method thereof
CN106366333B (en) A method of oxidation chitosan quaternary ammonium salt crosslinked with collagen
CN115926200A (en) Preparation method and application of enzyme-catalyzed double-crosslinked polymer composite hydrogel material
CN104497345A (en) Preparation method of hyaluronic acid-chitosan degradable dressing
CN105327389A (en) Collagen aggregate based flocculent antibacterial hemostatic material and preparation method thereof
CN108939132A (en) A kind of high bioactivity hyaluronic acid medical film and preparation method thereof based on the modification of low immunogenicity collagen
CN118236541A (en) Hydrogel dressing for accelerating diabetic wound healing and preparation method and application thereof
CN116077720B (en) Antibacterial double-layer hydrogel dressing and preparation method thereof
Magagula et al. Biopolymer-based biodegradable biomaterials for in vivo and in vitro biomedical applications
CN107080858A (en) A kind of wound repair plural gel and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant